Luminex Corporation recalls Vergene Amplification Tray - 700uL, BC-GP REF 20-011-018 The Verigene(R) Gram-Positive Blood Culture Nucleic Acid Test…
- Recall date
- December 26, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0822-2019
- FDA classification
- Class III
- Brand / firm
- Luminex Corporation
- Sold / distributed
- Worldwide Distribution: US (nationwide) and countries of: Austria, and Italy.
Why it was recalled
On lot of VERIGENE(R) BC-GP Utility Kits (20-011-018) were labeled with the VERIGENE(R) Amplification Tray label.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Vergene Amplification Tray - 700uL, BC-GP REF 20-011-018 The Verigene(R) Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI). BC-GP is performed directly on blood culture bottles identified as positive by a continuous monitoring blood culture system and which contain gram-positive bacteria.
Get recall alerts
Free email alert whenever Luminex Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Luminex Corporation